Aclairo Pharmaceutical Development Group's Acquisition

Aclairo Pharmaceutical Development Group was acquired by Experimental Pathology Laboratories on January 13, 2016.

Aclairo's experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development. The Company's advanta…

Articles about Aclairo Pharmaceutical Development Group's Acquisition: